Wednesday, April 23, 2025

Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop® System Sequences

Related stories

GitLab and AWS Unveil GitLab Duo with Amazon Q to Revolutionize AI-Powered Software Development

GitLab, the most comprehensive AI-powered DevSecOps platform, has officially...

Scrut Automation Launches Scrut Teammates: AI-Powered GRC Agents Designed for Growth-Driven Enterprises

Scrut Automation, the company behind the next-generation Governance, Risk,...

Varonis and Pure Storage Join Forces to Deliver Industry-First Native Data Security Integration

Varonis Systems, has announced a strategic partnership with Pure...

Endace Integrates with Microsoft Sentinel for Deep Network Visibility

Packet capture authority Endace announced an integration between EndaceProbe and Microsoft...
spot_imgspot_img

Hyperfine, Inc., the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared portable magnetic resonance brain imaging system—the Swoop® system—announced FDA clearance of updated software. Built on a robust AI foundation, the latest software brings image quality enhancements to the Swoop® system’s diffusion-weighted imaging (DWI) sequence.

With this latest software update, Hyperfine, Inc. expands the Swoop® system’s AI denoising capabilities by incorporating advanced image post-processing into the DWI sequence. The system’s other sequences (T1, T2, and FLAIR) previously benefited from this AI feature. Denoising enables a crisper image that potentially helps clinicians more accurately diagnose, treat, and monitor patients undergoing brain imaging.

Also Read: Klick Health Launches First ChatGPT Plugin for Life Sciences Industry in US

“We believe in making brain imaging more accessible, clinically relevant, and actionable. We continue to make meaningful progress across all sequences. With this significant and most recent update, we now incorporate deep learning into our DWI sequence,” said Tom Teisseyre, chief operating officer of Hyperfine, Inc. “These imaging improvements will serve a critical role in enhancing image quality for healthcare professionals in time-sensitive environments.”

Maria Sainz, president and CEO of Hyperfine, Inc., remarked, “Our eighth FDA software clearance in three years for the Swoop® system underscores our relentless drive for innovation and continuous improvement. Our focus remains on providing quality brain imaging to more providers and patients in more sites of care. More than milestones, it’s about reshaping patient care, empowering clinicians, and advancing brain imaging.”

SOURCE: BusinessWire

Subscribe

- Never miss a story with notifications


    Latest stories

    spot_img